Ex Parte HORWITZ - Page 2




            Appeal No. 2002-1740                                                                              
            Application No. 08/447,398                                                                        

                   Claim 47 is illustrative of the claims on appeal and reads as follows:                     
                   47.  A vaccinating agent for use in immunizing a mammalian host susceptible to             
            disease caused by a pathogen from the genus Mycobacterium, comprising a                           
            recombinant purified Mycobacterium 32 kD extracellular protein, and an adjuvant, with             
            the proviso that said vaccinating agent does not contain an immunologically protective            
            amount of unpurified Mycobacterium extracellular protein.                                         
                   The prior art references relied upon by the examiner are:                                  
            Borremans, M., et al., “Cloning, Sequence Determination, and Expression of a 32 -                 
            Kilodalton-Protein Gene of Mycobacterium tuberculosis,” Infection and Immunity, Vol.              
            57, No. 10, pp. 3123-3130 (1989)                                                                  
            Pal, P.G., et al., “Immunization with Extracellular Proteins of Mycobacterium                     
            tuberculosis Induces Cell-Mediated Immune Responses and Substantial Protective                    
            Immunity in a Guinea Pig Model of Pulmonary Tuberculosis,” Infection and Immunity,                
            Vol. 60, No. 11, pp 4781-4792 (1992)                                                              
            Salata, R.A., et al., “Purification and Characterization of the 30,000 dalton Native              
            Antigen of Mycobacterium tuberculosis and Characterization of Six Monoclonal                      
            Antibodies Reactive with a Major Epitope of This Antigen,” Journal of Laboratory and              
            Clinical Medicine, Vol. 118, pp. 589-598 (1991)                                                   
            Wallis, R.S., et al., “Identification by Two-Dimensional Gel Electrophoresis of a 58              
            Kilodalton Tumor Necrosis Factor-Inducing Protein of Mycobacterium tuberculosis,”                 
            Infection and Immunity, Vol. 61, No. 2, pp. 627-632 (1993)                                        
            Zhang, Y., et al., “Genetic Analysis of Superoxide Dismutase, the 23 Kilodalton Antigen           
            of Mycobacterium tuberculosis,” Molecular Microbiology, Vol. 5, No. 2, pp. 381-391                
            (1991)                                                                                            
            Munk, M.E., et al., “T Cell Responses of Normal Individuals Towards Recombinant                   
            Protein Antigens of Mycobacterium tuberculosis,” European Journal of Immunology,                  
            Vol. 18, pp. 1835-1838 (1988)                                                                     
            Verbon, A., et al., “Ontwikkeling van een seriolgiche test voor tuberculose,” Nederlands          
            Tudscrift voor Geneeskunde, Vol. 135, No. 4, pp. 134-138 (1991)                                   
            Wiegeshaus, E., et al., “Evaluation of Protective Potency of New Tuberculosis                     
            Vaccines,” Reviews of Infectious Diseases, Vol. 11, Suppl. 2, pp. S484-S490 (1989)                
                                                      2                                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007